Three-year Outcomes per PD-L1 Status and Continued Cemiplimab Beyond Progression plus Chemotherapy: EMPOWER-Lung 1
M. C. Garassino,S. Kilickap,M. Ozguroglu,A. Sezer, M. Gumus,I. Bondarenko, M. Gogishvili, M. Nechaeva,M. Schenker,I. Cicin,H. G. Fuang, Y. Kulyaba, M. Dvorkin, K. Zyuhal, R. -I. Scheusan, X. He, M. Kaul,E. Okoye,Y. Li,S. Li,J. -F. Pouliot, F. Seebach, I. Lowy, G. Gullo, P. Rietschel JOURNAL OF THORACIC ONCOLOGY（2023）
AI 理解论文
溯源树
样例
